Analyst picks & changes
By BC Staff | May 11, 2015 | 7:00 AM GMT
Analyst picks & changes
| Analyst picks & changes |
| Company | Bank | Analyst | Coverage | Opinion | Wk chg | 5/8 cls |
| CorMedix Inc. (NYSE-M:CRMD) | Roth Capital Partners | Scott Henry | Downgrade | Neutral (from buy) | -6% | $7.15 |
| Henry downgraded after a significant run up in the share price to about $8 from about $1 in January. He attributes the rise to regulatory designations with the potential to speed up clinical progress and speculation surrounding the appointment of Evercore
|
Read the full 577 word article
